DK0915702T3 - Anvendelse af et dehydroepiandrosteronderivat til forøgelse eller fremskyndelse af reepitelisering eller re-endotelisering af et væv - Google Patents
Anvendelse af et dehydroepiandrosteronderivat til forøgelse eller fremskyndelse af reepitelisering eller re-endotelisering af et vævInfo
- Publication number
- DK0915702T3 DK0915702T3 DK97936184T DK97936184T DK0915702T3 DK 0915702 T3 DK0915702 T3 DK 0915702T3 DK 97936184 T DK97936184 T DK 97936184T DK 97936184 T DK97936184 T DK 97936184T DK 0915702 T3 DK0915702 T3 DK 0915702T3
- Authority
- DK
- Denmark
- Prior art keywords
- endothelialization
- epithelialization
- following
- tissue
- skin
- Prior art date
Links
- FMGSKLZLMKYGDP-USOAJAOKSA-N dehydroepiandrosterone Chemical class C1[C@@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 FMGSKLZLMKYGDP-USOAJAOKSA-N 0.000 title abstract 2
- 230000009089 cytolysis Effects 0.000 abstract 2
- 210000001519 tissue Anatomy 0.000 abstract 2
- 208000003918 Acute Kidney Tubular Necrosis Diseases 0.000 abstract 1
- 208000002177 Cataract Diseases 0.000 abstract 1
- 208000035874 Excoriation Diseases 0.000 abstract 1
- 102000009123 Fibrin Human genes 0.000 abstract 1
- 108010073385 Fibrin Proteins 0.000 abstract 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 abstract 1
- 206010038540 Renal tubular necrosis Diseases 0.000 abstract 1
- 208000002847 Surgical Wound Diseases 0.000 abstract 1
- 238000002399 angioplasty Methods 0.000 abstract 1
- 210000004204 blood vessel Anatomy 0.000 abstract 1
- 239000003518 caustics Substances 0.000 abstract 1
- 210000004087 cornea Anatomy 0.000 abstract 1
- 210000004351 coronary vessel Anatomy 0.000 abstract 1
- 238000002651 drug therapy Methods 0.000 abstract 1
- 210000003038 endothelium Anatomy 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 210000000981 epithelium Anatomy 0.000 abstract 1
- 229950003499 fibrin Drugs 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 210000000214 mouth Anatomy 0.000 abstract 1
- 230000000241 respiratory effect Effects 0.000 abstract 1
- 238000001356 surgical procedure Methods 0.000 abstract 1
- 230000008733 trauma Effects 0.000 abstract 1
- 210000005239 tubule Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/695,769 US5929060A (en) | 1992-05-01 | 1996-08-01 | Method for enhancing or accelerating re-epithelialization or re-endothelialization of a tissue |
| US86917797A | 1997-06-05 | 1997-06-05 | |
| US08/901,085 US5922701A (en) | 1992-05-01 | 1997-07-28 | Method for enhancing or accelerating re-epithelialization or re-endothelialization of a tissue |
| PCT/US1997/012954 WO1998005338A2 (en) | 1996-08-01 | 1997-07-31 | Use of a dehydroepiandrosterone derivative for enhancing or accelerating re-epithelialization or re-endothelialization of a tissue |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0915702T3 true DK0915702T3 (da) | 2002-08-12 |
Family
ID=27418624
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK97936184T DK0915702T3 (da) | 1996-08-01 | 1997-07-31 | Anvendelse af et dehydroepiandrosteronderivat til forøgelse eller fremskyndelse af reepitelisering eller re-endotelisering af et væv |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5922701A (da) |
| EP (1) | EP0915702B1 (da) |
| JP (1) | JP2002514168A (da) |
| AT (1) | ATE216242T1 (da) |
| AU (1) | AU713850B2 (da) |
| CA (1) | CA2262086C (da) |
| DE (1) | DE69712065T2 (da) |
| DK (1) | DK0915702T3 (da) |
| ES (1) | ES2174275T3 (da) |
| WO (1) | WO1998005338A2 (da) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020091155A1 (en) * | 1995-06-22 | 2002-07-11 | Btg Pharmaceutical Corp. | Method for ameliorating muscle weakness/wasting in a patient infected with human immunodeficiency virus-type 1 |
| US6576659B1 (en) * | 1996-12-05 | 2003-06-10 | Bio-Technology General Corp. | Use of oxandrolone in the treatment of burns an other wounds |
| EP0908183A1 (en) * | 1997-10-08 | 1999-04-14 | Institute For Advanced Skin Research Inc. | Dehydroepiandrosterone or derivatives thereof for increasing the content of hyaluronic acid in skin |
| US6667299B1 (en) * | 2000-03-16 | 2003-12-23 | Hollis-Eden Pharmaceuticals, Inc. | Pharmaceutical compositions and treatment methods |
| US20080015174A1 (en) * | 1998-11-24 | 2008-01-17 | Reading Christopher L | Metabolic Disease Treatments |
| EP1228083A2 (en) * | 1999-09-30 | 2002-08-07 | Hollis-Eden Pharmaceuticals Inc. | Therapeutic treatment of androgen receptor driven conditions |
| FR2803750B1 (fr) * | 2000-01-17 | 2004-04-02 | Assist Publ Hopitaux De Paris | Utilisation par voie orale de la dehydroepiandrosterone, de ses precurseurs biologiques et de ses derives metaboliques comme anti-atrophiant |
| EP1174080B1 (en) | 2000-07-19 | 2012-01-18 | Critical Perfusion, Inc. | Catheter for use in a system for monitoring mucosal damage in hollow viscous organs |
| FR2831440B1 (fr) * | 2001-10-25 | 2003-12-26 | Oreal | Composition cosmetique, renfermant un derive de la dhea et un agent apaisant |
| US20040121991A1 (en) * | 2002-12-20 | 2004-06-24 | Araneo Barbara A. | Dehydroepiandrosterone (DHEA) congeners for prevention and/or treatment of ulcers |
| WO2004089304A2 (en) * | 2003-04-01 | 2004-10-21 | Hollis-Eden Pharmaceuticals, Inc. | Antiandrogens with marginal agonist activity and methods of use |
| US20050026883A1 (en) * | 2003-07-31 | 2005-02-03 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease |
| CA2582231A1 (en) * | 2004-09-29 | 2006-10-19 | Hollis-Eden Pharmaceuticals, Inc. | Steroid analogs and uses |
| US20060073099A1 (en) * | 2004-10-01 | 2006-04-06 | Frincke James M | Treatment screening methods |
| US8697152B2 (en) | 2005-08-31 | 2014-04-15 | Johnson & Johnson Consumer Companies, Inc. | Anti-inflammatory compositions and personal care compositions comprising olive leaf (Olea europea) extract |
| US8758838B2 (en) | 2005-08-31 | 2014-06-24 | Johnson & Johnson Consumer Companies, Inc. | Anti-inflammatory compositions and methods of use |
| WO2009124300A2 (en) | 2008-04-03 | 2009-10-08 | Hollis-Eden Pharmaceuticals, Inc. | Solid state forms of a pharmaceutical |
| CA2724130C (en) | 2008-06-06 | 2016-04-26 | Harbor Biosciences, Inc. | Methods for preparing 17-alkynyl-7-hydroxy steroids and related compounds |
| US20250002526A1 (en) * | 2021-10-22 | 2025-01-02 | Kyushu University, National University Corporation | Pharmaceutical composition having anti-cancer immunostimulating effect and/or immune checkpoint inhibition potentiating effect |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5001119A (en) * | 1987-11-25 | 1991-03-19 | Schwartz Arthur G | 16-substituted androstanes and 16-substituted androstenes |
| US5175154A (en) * | 1987-11-25 | 1992-12-29 | Research Corporation Technologies, Inc. | 5 α-pregnan-20-ones and 5-pregnen-20-ones and related compounds |
| US4898694A (en) * | 1987-11-25 | 1990-02-06 | Schwartz Arthur G | 17-Hydroxy-steroids |
| US5162198A (en) * | 1991-02-08 | 1992-11-10 | Virginia Commonwealth University | Method of using dehydroepiandrosterone and dehydroepiandrosterone-sulfate as inhibitors of thrombuxane production and platelet aggregation |
| US5110810A (en) * | 1991-02-08 | 1992-05-05 | Virginia Commonwealth University | Method of using dehydroepiandrosterone and dehydroepiandrosterone-sulfate as inhibitors of platelet aggregation |
| EP0637915A4 (en) * | 1992-05-01 | 1998-09-02 | Univ Utah Res Found | Compositions and methods for regulating il-6 production in vivo. |
| US5686438A (en) * | 1993-03-09 | 1997-11-11 | University Of Utah Research Foundation | Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
| FI953814L (fi) * | 1993-03-09 | 1995-11-07 | Univ Utah Res Found | Menetelmät progressiivisen kudoskuolion, bakteerien translokaation, reperfuusiovaurion ja hengityksen vajaatoiminnan estämiseksi |
| US5635496A (en) * | 1993-03-09 | 1997-06-03 | University Of Utah Research Foundation | Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
| US5587369A (en) * | 1993-03-09 | 1996-12-24 | University Of Utah Research Foundation | Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
| FR2729854A1 (fr) * | 1995-01-26 | 1996-08-02 | Oreal | Utilisation du sulfate de dehydroepi-androsterone dans une composition cosmetique ou dermatologique |
-
1997
- 1997-07-28 US US08/901,085 patent/US5922701A/en not_active Expired - Fee Related
- 1997-07-31 AT AT97936184T patent/ATE216242T1/de not_active IP Right Cessation
- 1997-07-31 JP JP50797298A patent/JP2002514168A/ja not_active Ceased
- 1997-07-31 WO PCT/US1997/012954 patent/WO1998005338A2/en not_active Ceased
- 1997-07-31 DK DK97936184T patent/DK0915702T3/da active
- 1997-07-31 ES ES97936184T patent/ES2174275T3/es not_active Expired - Lifetime
- 1997-07-31 CA CA002262086A patent/CA2262086C/en not_active Expired - Fee Related
- 1997-07-31 DE DE69712065T patent/DE69712065T2/de not_active Expired - Fee Related
- 1997-07-31 EP EP97936184A patent/EP0915702B1/en not_active Expired - Lifetime
- 1997-07-31 AU AU38917/97A patent/AU713850B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998005338A3 (en) | 1998-03-26 |
| DE69712065T2 (de) | 2002-11-07 |
| CA2262086C (en) | 2003-11-11 |
| ATE216242T1 (de) | 2002-05-15 |
| JP2002514168A (ja) | 2002-05-14 |
| EP0915702A2 (en) | 1999-05-19 |
| DE69712065D1 (de) | 2002-05-23 |
| EP0915702B1 (en) | 2002-04-17 |
| WO1998005338A2 (en) | 1998-02-12 |
| AU713850B2 (en) | 1999-12-09 |
| ES2174275T3 (es) | 2002-11-01 |
| US5922701A (en) | 1999-07-13 |
| AU3891797A (en) | 1998-02-25 |
| CA2262086A1 (en) | 1998-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0915702T3 (da) | Anvendelse af et dehydroepiandrosteronderivat til forøgelse eller fremskyndelse af reepitelisering eller re-endotelisering af et væv | |
| O'BRIEN et al. | Successful transfer of a large island flap from the groin to the foot by microvascular anastomoses | |
| Fine et al. | Early clinical experience in endoscopic-assisted muscle flap harvest | |
| Jaggers et al. | Injury to popliteal vessels | |
| Sadove | Successful replantation of a totally amputated ear | |
| GER | The coverage of vascular repairs by muscle transposition | |
| Mains et al. | Report on compound dislocation of the elbow with entrapment of the brachial artery. | |
| Huemer et al. | Gracilis muscle flap for aesthetic reconstruction in the head and neck region | |
| Germann et al. | Two new applications for the first dorsal metacarpal artery pedicle in the treatment of severe hand injuries | |
| RU2345718C2 (ru) | Способ лечения окклюзий бедренно-подколенного артериального сегмента | |
| Rosato et al. | Subcutaneous fasciotomy—description of a new technique and instrument | |
| Isenberg et al. | The limited value of preoperative angiography in microsurgical reconstruction of the lower limb | |
| Khauli et al. | Laparoscopic donor nephrectomy: overcoming the learning curve | |
| Gravvanis et al. | Microvascular repair following crush‐avulsion type injury with vein grafts: Effect of direct inhibitors of thrombin on patency rate | |
| Rubens et al. | Brachiocephalic fistula: a useful alternative for vascular access in chronic hemodialysis | |
| MORRIS et al. | Aneurysm of the posterior tibial artery after a foot stabilization procedure: a case report | |
| Mansfield et al. | The care of vascular endothelium in pediatric surgery | |
| RU2195877C2 (ru) | Способ селективной эндоскопической диссекции перфорантных вен голени при хронической венозной недостаточности нижних конечностей | |
| Harii | Microvascular surgery in plastic surgery: Free‐tissue transfer | |
| Tanaka et al. | Replantation of a large amputated segment of the face: A new technique | |
| RU2131209C1 (ru) | Способ хирургического лечения глубоких ожогов у детей | |
| Berger et al. | Free latissimus dorsi muscle transfer in extensive soft tissue defects of the lower leg | |
| SU1635971A1 (ru) | Способ хирургического лечени рубцовой деформации шеи | |
| SU1360717A1 (ru) | Способ лечени поврежденного проксимального межфалангового сустава пальца кисти | |
| Longmire | Thromboendarterectomy for localized occlusion of the terminal aorta: A case report: Re-enforcement of the aortic wall with a skin graft |